Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement of Rocket Pharmaceuticals, Inc. on Form S-3 to be filed on or about August 15, 2024 of our reports dated February 27, 2024, on our audits of the financial statements as of December 31, 2023 and 2022 and for each of the years in the three-year period ended December 31, 2023 and the effectiveness of Rocket Pharmaceutical Inc.’s internal control over financial reporting as of December 31, 2023, which reports were included in the Annual Report on Form 10-K filed February 27, 2024. We also consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form S-3.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New York
August 15, 2024